Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha 410008.
Hunan Province Key Laboratory of Otorhinolaryngology Critical Diseases, Changsha 410008, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Aug 28;46(8):843-850. doi: 10.11817/j.issn.1672-7347.2021.200996.
To evaluate feasibility and efficacy of surgical approach of laryngofissure combined with epiglottis valley in treating locally-advanced pyriform sinus carcinoma.
Clinical data of 216 patients with T3 and T4a pyriform sinus carcinoma, who came from the Department of Otorhinolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University between January 2013 and December 2019, were retrospectively analyzed. Three different types of surgery were used in these patients. Seventy-three patients were performed by approach of laryngofissure combined with epiglottis valley for partial laryngopharyngectomy (Group I); 75 patients were performed by approach of lateral pharynx for piriform fossa resection (Group II); 68 patients were performed by total laryngopharyngectomy (Group III). All patients were treated with radiotherapy and followed up regularly after operation. Kaplan-Meier regression model was used to analyze the overall survival rate. EAT-10 swallowing scale was utilized to evaluate the postoperative swallowing function, while the rate of tracheal tube extubation and the incidence of postoperative complications in each group were compared.
There were 76.7% patients with T3 stage in Group I, 100% patients with T3 stage in Group II, and 64.7% patients with T4a stage in Group III. There was significant difference between them (<0.01). Clinical stage IV patients in the Group I, Group II, and Group III were 74.0%, 54.7%, and 89.7%, respectively, with significant difference (<0.01). The 3-year overall survival (OS) rate in Group I, Group II, and Group III were 69.9%, 53.3%, and 58.8%, respectively. Patients in the Group I had a better survival outcome than that in the Group II (<0.05). The median score of EAT-10 swallowing scale was 12.0 in the Group I, 8.0 in Group II, and 5.0 in Group III, with significant difference (<0.01). There was no significant difference in the rate of tracheal tube extubation and the incidence of complication among the 3 groups (both 0.05).
Surgical approach of laryngofissure combined with epiglottis valley in the treating locally-advanced piriform sinus carcinoma presents favorable outcome in terms of survival rate and laryngeal function preservation, which deserves to be promoted.
评估喉裂开联合会厌谷入路在治疗局部晚期梨状窝癌中的可行性和疗效。
回顾性分析 2013 年 1 月至 2019 年 12 月中南大学湘雅医院耳鼻咽喉头颈外科收治的 216 例 T3 和 T4a 梨状窝癌患者的临床资料。这些患者采用了三种不同的手术方式。73 例采用喉裂开联合会厌谷入路行部分喉咽环周切除术(I 组);75 例采用咽侧入路行梨状窝切除术(II 组);68 例行全喉咽环周切除术(III 组)。所有患者术后均行放疗,并定期随访。采用 Kaplan-Meier 回归模型分析总生存率。采用 EAT-10 吞咽量表评估术后吞咽功能,比较各组患者气管拔管率和术后并发症发生率。
I 组 T3 期患者占 76.7%,II 组 T3 期患者占 100%,III 组 T4a 期患者占 64.7%。三组间差异有统计学意义(<0.01)。I 组、II 组和 III 组的 IV 期临床患者分别为 74.0%、54.7%和 89.7%,差异有统计学意义(<0.01)。I 组、II 组和 III 组患者的 3 年总生存率(OS)分别为 69.9%、53.3%和 58.8%。I 组患者的生存结果优于 II 组(<0.05)。I 组 EAT-10 吞咽量表评分中位数为 12.0,II 组为 8.0,III 组为 5.0,差异有统计学意义(<0.01)。三组患者气管拔管率和并发症发生率差异均无统计学意义(均 P>0.05)。
喉裂开联合会厌谷入路治疗局部晚期梨状窝癌在生存率和喉功能保留方面具有较好的效果,值得推广。